Cargando…
P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429608/ http://dx.doi.org/10.1097/01.HS9.0000968512.20949.2b |
| _version_ | 1785090757427724288 |
|---|---|
| author | Lu, Jing Zhou, Huifen Zhou, Xin Yang, Yonggong Tong, Laigen Miao, Miao Yang, Xiaofei Chen, Suning |
| author_facet | Lu, Jing Zhou, Huifen Zhou, Xin Yang, Yonggong Tong, Laigen Miao, Miao Yang, Xiaofei Chen, Suning |
| author_sort | Lu, Jing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429608 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104296082023-08-17 P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY Lu, Jing Zhou, Huifen Zhou, Xin Yang, Yonggong Tong, Laigen Miao, Miao Yang, Xiaofei Chen, Suning Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429608/ http://dx.doi.org/10.1097/01.HS9.0000968512.20949.2b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lu, Jing Zhou, Huifen Zhou, Xin Yang, Yonggong Tong, Laigen Miao, Miao Yang, Xiaofei Chen, Suning P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
| title | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
| title_full | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
| title_fullStr | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
| title_full_unstemmed | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
| title_short | P401: INNOVATIVE REDUCED-DOSE CHEMOTHERAPY FOLLOWED BY BLINATUMOMAB INDUCTION THERAPY FOR SUCCESSFUL MANAGEMENT OF TREATMENT NAIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA ADULTS: A MULTICENTER, REAL-WORLD STUDY |
| title_sort | p401: innovative reduced-dose chemotherapy followed by blinatumomab induction therapy for successful management of treatment naive b-cell acute lymphoblastic leukemia adults: a multicenter, real-world study |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429608/ http://dx.doi.org/10.1097/01.HS9.0000968512.20949.2b |
| work_keys_str_mv | AT lujing p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT zhouhuifen p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT zhouxin p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT yangyonggong p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT tonglaigen p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT miaomiao p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT yangxiaofei p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy AT chensuning p401innovativereduceddosechemotherapyfollowedbyblinatumomabinductiontherapyforsuccessfulmanagementoftreatmentnaivebcellacutelymphoblasticleukemiaadultsamulticenterrealworldstudy |